Christian Schumann

5.8k total citations · 1 hit paper
141 papers, 3.7k citations indexed

About

Christian Schumann is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Christian Schumann has authored 141 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Pulmonary and Respiratory Medicine, 56 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Christian Schumann's work include Lung Cancer Treatments and Mutations (53 papers), Lung Cancer Diagnosis and Treatment (27 papers) and Lung Cancer Research Studies (22 papers). Christian Schumann is often cited by papers focused on Lung Cancer Treatments and Mutations (53 papers), Lung Cancer Diagnosis and Treatment (27 papers) and Lung Cancer Research Studies (22 papers). Christian Schumann collaborates with scholars based in Germany, United States and United Kingdom. Christian Schumann's co-authors include Thomas Wibmer, Kathy Triantafilou, Philipp M. Lepper, Martha Triantafilou, J. Ballongue, Philipp M. Lepper, Rolf Diller, Martin Hetzel, Ruth T. Gross and K Stoiber and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Christian Schumann

129 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial

2015 331 citations Rodryg Ramlau, Christian Schumann et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christian Schumann Germany	36	1.4k	1.0k	765	406	387	141	3.7k
Gerhard Hamilton Austria	35	672 0.5×	1.5k 1.5×	1.2k 1.6×	372 0.9×	682 1.8×	160	3.8k
Mi Young Kim South Korea	34	2.0k 1.4×	1.1k 1.1×	701 0.9×	943 2.3×	894 2.3×	194	4.8k
Johan Malm Sweden	38	529 0.4×	505 0.5×	1.3k 1.7×	341 0.8×	350 0.9×	172	5.5k
Jeffrey B. Rubins United States	31	906 0.6×	449 0.4×	589 0.8×	237 0.6×	1.0k 2.7×	70	2.9k
Kyong Hwa Park South Korea	31	729 0.5×	1.2k 1.2×	1.2k 1.6×	651 1.6×	218 0.6×	219	3.9k
Michael A. Liss United States	39	2.3k 1.6×	787 0.8×	1.9k 2.5×	1.2k 3.0×	647 1.7×	261	5.2k
Tomoyuki Murakami Japan	35	654 0.5×	428 0.4×	1.2k 1.6×	719 1.8×	404 1.0×	160	4.6k
Reiko Ito Japan	34	417 0.3×	775 0.8×	1.5k 2.0×	658 1.6×	405 1.0×	126	3.7k
Takeshi Sano Japan	37	952 0.7×	519 0.5×	2.1k 2.8×	991 2.4×	372 1.0×	177	4.8k
Mary C. Rose United States	32	1.6k 1.1×	291 0.3×	1.6k 2.1×	369 0.9×	419 1.1×	71	4.0k

Countries citing papers authored by Christian Schumann

Since Specialization

Citations

This map shows the geographic impact of Christian Schumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Schumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Schumann more than expected).

Fields of papers citing papers by Christian Schumann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Schumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Schumann. The network helps show where Christian Schumann may publish in the future.

Co-authorship network of co-authors of Christian Schumann

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Schumann. A scholar is included among the top collaborators of Christian Schumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Schumann. Christian Schumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Streit, Frank, Christian Schumann, Anna Dudakova, et al.. (2023). Feasibility of Continuous Infusion of Cefiderocol in Conjunction with the Establishment of Therapeutic Drug Monitoring in Patients with Extensively Drug-Resistant Gram-Negative Bacteria. Clinical Drug Investigation. 43(4). 307–314. 5 indexed citations

Sharma, Amita, Tobias Sikosek, Timothy Rajakumar, et al.. (2023). Early detection of lung cancer using small RNAs.. Journal of Clinical Oncology. 41(16_suppl). 3035–3035.

Stratmann, Jan, Nikolaj Frost, Petros Christopoulos, et al.. (2023). 1405P Sotorasib in KRAS G12C-mutated NSCLC: A multicenter real-world experience from the expanded access program in Germany. Annals of Oncology. 34. S804–S804. 1 indexed citations

Kuon, Jonas, Stefan Wilop, Dirk Behringer, et al.. (2023). 1448P First-line nivolumab (NIVO) plus ipilimumab (IPI) with two cycles of chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC): Results from an interim analysis of the non-interventional FINN study. Annals of Oncology. 34. S823–S824.

Kuttler, Christina, et al.. (2021). How mathematical modeling could contribute to the quantification of metastatic tumor burden under therapy: insights in immunotherapeutic treatment of non-small cell lung cancer. Theoretical Biology and Medical Modelling. 18(1). 11–11. 10 indexed citations

Scagliotti, Giorgio V., Denis Moro‐Sibilot, Jens Kollmeier, et al.. (2019). A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-Line Treatment for EGFR Mutation–Positive NSCLC Patients. Journal of Thoracic Oncology. 15(1). 80–90. 60 indexed citations

Schuette, Wolfgang, Claus-Peter Schneider, Walburga Engel-Riedel, et al.. (2017). 65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer. SHILAP Revista de lepidopterología. Volume 8. 217–229. 8 indexed citations

Gorges, Tobias M., Simon A. Joosse, Sabine Riethdorf, et al.. (2015). Enumeration and Molecular Characterization of Tumor Cells in Lung Cancer Patients Using a Novel In Vivo Device for Capturing Circulating Tumor Cells. Clinical Cancer Research. 22(9). 2197–2206. 129 indexed citations

Schuette, Wolfgang, Peter Schirmacher, Wilfried Eberhardt, et al.. (2015). EGFR Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational Study. Cancer Epidemiology Biomarkers & Prevention. 24(8). 1254–1261. 29 indexed citations

10.

Schumann, Christian & Anja Hennemuth. (2015). Three-dimensional Visualization of Relative Pressure in Vascular Structures.. Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft). 337–342. 3 indexed citations

11.

Thatcher, N., T-E. Ciuleanu, Rodryg Ramlau, et al.. (2015). Subgroup Analysis of Elderly Patients in Squire: a Randomized, Multicenter, Open-Label, Phase Iii Study of Necitumumab (N) Plus Gemcitabine-Cisplatin (GC) Chemotherapy Versus Gc Alone in First-Line Treatment of Patients (PTS) with Stage Iv Squamous Non-Small Cell Lung Cancer (SQ-NSCLC). Annals of Oncology. 26. i29–i29. 3 indexed citations

12.

Watz, Henrik, Johannes Nagelschmitz, Frauke Pedersen, et al.. (2014). Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum. European Respiratory Journal. 44(Suppl 58). P2049–P2049. 2 indexed citations

13.

Yousif, Nasser Ghaly & Christian Schumann. (2014). Survival rates between premenopausal and postmenopausal women with lung cancer: US SEER database. 2(4). 270–276.

14.

Kreuter, Michael, Johan Vansteenkiste, J.R. Fischer, et al.. (2012). Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study. Annals of Oncology. 24(4). 986–992. 56 indexed citations

15.

Lepper, Philipp M., Sebastian R. Ott, Hanno Hoppe, et al.. (2011). Superior Vena Cava Syndrome in Thoracic Malignancies. Respiratory Care. 56(5). 653–666. 63 indexed citations

16.

Schumann, Christian, Stefan Rüdiger, Stefan Boeck, et al.. (2011). Pharmacogenetic predictors for EGFR-inhibitor-associated skin toxicity. The Pharmacogenomics Journal. 13(2). 181–188. 29 indexed citations

17.

Schuette, Wolfgang, S. Nagel, Ludwig Fischer von Weikersthal, et al.. (2011). Randomized Phase III Trial of Docetaxel Plus Carboplatin with or without Levofloxacin Prophylaxis in Elderly Patients with Advanced Non-small Cell Lung Cancer: The APRONTA Trial. Journal of Thoracic Oncology. 6(12). 2090–2096. 10 indexed citations

18.

Krüger, Stefan, Andreas K. Buck, Felix M. Mottaghy, et al.. (2009). Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 36(11). 1807–1812. 120 indexed citations

19.

Wibmer, Thomas, et al.. (2007). Schwere chronische respiratorische Insuffizienz bei adulter Glykogenose Typ II (Morbus Pompe) : Erfolgreiche Therapie mittels Enzymersatz. RWTH Publications (RWTH Aachen).

20.

Schumann, Christian, Ruth T. Gross, Norbert Michael, Tilman Lamparter, & Rolf Diller. (2007). Sub‐Picosecond Mid‐Infrared Spectroscopy of Phytochrome Agp1 from Agrobacterium tumefaciens. ChemPhysChem. 8(11). 1657–1663. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact